Guidelines on oral anticoagulation with warfarin - fourth edition

被引：404

作者：

Keeling, David ^{[1
]}

Baglin, Trevor ^{[2
]}

Tait, Campbell ^{[3
]}

Watson, Henry ^{[4
]}

Perry, David ^{[2
]}

Baglin, Caroline ^{[2
]}

Kitchen, Steve ^{[5
]}

Makris, Michael ^{[5
]}

机构：

[1] Oxford Radcliffe Hosp, Oxford, England

[2] Addenbrookes Hosp, Cambridge, England

[3] Glasgow Royal Infirm, Glasgow G4 0SF, Lanark, Scotland

[4] Aberdeen Royal Infirm, Aberdeen, Scotland

[5] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2011年 / 154卷 / 03期

关键词：

warfarin; anticoagulation; vitamin K antagonist; DEEP-VEIN THROMBOSIS; INTERNATIONAL NORMALIZED RATIO; FATAL PULMONARY-EMBOLISM; RECURRENT VENOUS THROMBOEMBOLISM; VITAMIN-K SUPPLEMENTATION; LONG-TERM ANTICOAGULATION; ATRIAL-FIBRILLATION; ANTITHROMBOTIC THERAPY; ANTIPLATELET THERAPY; LOW-INTENSITY;

D O I：

10.1111/j.1365-2141.2011.08753.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：311 / 324

页数：14

共 111 条

[1] Extended oral anticoagulant therapy after a first episode of pulmonary embolism [J].

Agnelli, G ;

Prandoni, P ;

Becattini, C ;

Silingardi, M ;

Taliani, MR ;

Miccio, M ;

Imberti, D ;

Poggio, R ;

Ageno, W ;

Pogliani, E ;

Porro, F ;

Zonzin, P .

ANNALS OF INTERNAL MEDICINE, 2003, 139 (01) :19-25

[2] Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. [J].

Agnelli, G ;

Prandoni, P ;

Santamaria, MG ;

Bagatella, P ;

Iorio, A ;

Bazzan, M ;

Moia, M ;

Guazzaloca, G ;

Bertoldi, A ;

Tomasi, C ;

Scannapieco, G ;

Ageno, W ;

Ascani, A ;

Villalta, S ;

Frulla, M ;

Mosena, L ;

Girolami, A ;

Vaccarino, A ;

Alatri, A ;

Palareti, G ;

Marchesi, M ;

Ambrosio, GB ;

Parisi, R ;

Doria, S ;

Steidl, L ;

Ambrosini, F ;

Silingardi, M ;

Ghirarduzzi, A ;

Iori, I .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :165-169

[3] The effects of oral anticoagulants in patients with peripheral arterial disease: Rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials [J].

Anand, S ;

Yusuf, S ;

Montague, P ;

Chin, SL .

AMERICAN HEART JOURNAL, 2006, 151 (01) :1-9

[4]

Anand S, 2007, NEW ENGL J MED, V357, P217

[5] Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis [J].

Andersen, L. V. ;

Vestergaard, P. ;

Deichgraeber, P. ;

Lindholt, J. S. ;

Mortensen, L. S. ;

Frost, L. .

HEART, 2008, 94 (12) :1607-1613

[6]

[Anonymous], 1998, Br J Haematol, V101, P374

[7]

[Anonymous], COCHRANE DATABASE SY

[8]

[Anonymous], 2009, BMJ, DOI DOI 10.1136/BMJ.B4531

[9] Unprovoked deep vein thrombosis should be treated with long-term anticoagulation - no [J].

Baglin, T. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (12) :2336-2339

[10] Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis [J].

Baglin, T. ;

Douketis, J. ;

Tosetto, A. ;

Marcucci, M. ;

Cushman, M. ;

Kyrle, P. ;

Palareti, G. ;

Poli, D. ;

Tait, R. C. ;

Iorio, A. .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2010, 8 (11) :2436-2442

← 1 2 3 4 5 6 7 8 9 10 →